comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 22:58:47 - browse：5

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

focus

WSS

FDA's naming rule on biosimilars has undermined competition

Eliminate the waiting period for sterilization covered by Medicaid

H5N1 bird flu: what we're starting to learn about infection in cows

Why the world’s most expensive drug might be worth the price

H5N1 bird flu: what we're starting to learn about infection in cows

Vertex Pharmaceuticals may move headquarters in Boston

Wikipedia

comprehensive

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA's naming rule on biosimilars has undermined competition

Trump demands the U.S. pay no more for drugs than other countries … again

H5N1 communication has been strictly for the birds

Duchenne breakthrough therapy leaves behind pioneering families

Medicare says breakthrough device reimbursement rule to come by summer

Drug repurposing or repositioning? The language matters

Making AI in medicine accessible to smaller, and rural hospitals

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

focus

Readout LOUD podcast: What to know about H5N1 bird flu

Bird flu outbreak in cows is latest avian flu curveball

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Medicare says breakthrough device reimbursement rule to come by summer

First recipient of genetically engineered pig kidney has died

Abortion pill case raises question: who can sue the FDA?

focus

hotspot

focus

leisure time